XTalks

JULY 29, 2024

Orphan drug development poses many challenges that are unique to rare diseases, including recruitment in small patient populations, variable progression with heterogenous clinical manifestations and limited understanding of disease progression and natural history. Read on to learn key lessons in rare disease drug development.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Research 105

XTalks

DECEMBER 1, 2020

Over the past several years, personalized medicine has led the charge in medical innovation, leading drug development efforts as well as furthering the research community’s understanding of human disease states. A Global Lab Service Platform. Of course, as equally important as the science is the customer relationship.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

The Pharma Data

OCTOBER 27, 2020

Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY ® System. .” More information is available at www.agenabio.com. About Agena Bioscience. For more information about Agena, visit www.agenabio.com. View original content to download multimedia: [link].

Genetic Analysis 52

Genetic Analysis Genome Genomics Reagent 52